Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen – Biogen

1. Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen  Biogen
2. US FDA declines to approve higher dose of Biogen’s genetic disorder drug  Yahoo Finance
3. Biogen hit with setback in pursuit of high-dose Spinraza approval  FirstWord Pharma
4. FDA requests update to technical information of Biogen nusinersen sNDA  TipRanks
5. Biogen falls after US FDA declines to approve higher dose of co’s genetic disorder drug  TradingView

Continue Reading